Health
Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy – News-Medical.Net
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possib…
Reviewed by Emily Henderson, B.Sc.Oct 1 2020
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Adjuvant treatments, such as chemotherapy, radiation therapy or targeted therapies, are not usually offered to ILC patients after surgery as the disease is slo…
-
General23 hours agoFour bodies found in central Queensland house fire
-
General11 hours agoCarrie Bickmore named Victorian Australian of the Year for work to progress brain cancer research
-
General20 hours agoSydney man Danny Zayat found guilty of murdering Tatiana Dokhotaru in Liverpool apartment
-
Noosa News22 hours agoFour people killed as fire rips through home in Emerald, Queensland